[Clinical pharmacology of a new beta-adrenergic blocking agent--Trasicor]. 1973

B E Votchal, and I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ, and Z V Vorob'eva

UI MeSH Term Description Entries
D010096 Oxprenolol A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety. Coretal,Koretal,Oxprenolol Hydrochloride,Slow Trasicor,Tevacor,Trasicor,Hydrochloride, Oxprenolol,Trasicor, Slow
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac

Related Publications

B E Votchal, and I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ, and Z V Vorob'eva
January 1969, Acta medica Scandinavica,
B E Votchal, and I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ, and Z V Vorob'eva
December 1968, Current therapeutic research, clinical and experimental,
B E Votchal, and I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ, and Z V Vorob'eva
August 1962, Lancet (London, England),
B E Votchal, and I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ, and Z V Vorob'eva
October 1970, The Journal of pharmacology and experimental therapeutics,
B E Votchal, and I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ, and Z V Vorob'eva
July 1971, Indian heart journal,
B E Votchal, and I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ, and Z V Vorob'eva
April 1990, DICP : the annals of pharmacotherapy,
B E Votchal, and I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ, and Z V Vorob'eva
September 1973, Nihon rinsho. Japanese journal of clinical medicine,
B E Votchal, and I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ, and Z V Vorob'eva
October 1976, Journal of the Royal College of Physicians of London,
B E Votchal, and I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ, and Z V Vorob'eva
November 1976, The Journal of the Association of Physicians of India,
B E Votchal, and I P Zamotaev, and L G Lozinskiĭ, and B L Sandomirskiĭ, and Z V Vorob'eva
January 1973, Kardiologia polska,
Copied contents to your clipboard!